13F

Stock

Tarsus Pharmaceuticals, Inc.

TARS · held by 3 managers

Reported value

$5.17M

Holders

3

+0 new · −0 exited

Holders’ est. mark

−$574K

Price effect on 2 books still in the name

Largest holder

$5.17M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC127.6K$5.17M−$573.8KAdded$2.45M
Catherine Avery Investment Management LLC20$810−$142Added$142
Essential Partners LLC3$122Held

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.